Compare the published Medicare service mix of Sandra L. Aponte, MD, MBA with clinicians in the same registry specialty: Pathology (CMS).
TAMPA, FL · Exact areaEdit location
2024 published service data · 61 eligible profiles compared. Similarity describes billing patterns, not quality, outcomes, or suitability for your care.
Shared published services3 shared services · view billing descriptions
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
Pathology examination of tissue using a microscope, intermediate complexity (88305)
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
Shared published services3 shared services · view billing descriptions
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
Pathology examination of tissue using a microscope, intermediate complexity (88305)
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
Shared published services3 shared services · view billing descriptions
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
Pathology examination of tissue using a microscope, intermediate complexity (88305)
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
Shared published services3 shared services · view billing descriptions
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
Pathology examination of tissue using a microscope, intermediate complexity (88305)
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
We use the same calendar year of CMS Medicare Physician & Other Practitioners data for both providers. Published non-drug service counts are combined by HCPCS code across places of service. We apply log(1 + count), normalize the vectors, and compare them using cosine similarity.
Candidates share the reference provider’s current NPPES primary taxonomy and match the location you enter. We examine up to 500 candidates in NPI order, then show up to 12 with the highest positive similarity within that set. The score is not a percentile, medical recommendation, or prediction. Suppressed services are not estimated. Medicare fee-for-service data does not describe a provider’s entire practice.
Optional analytics help us improve HCPList. Search terms and provider identifiers are excluded from analytics. Essential cookies keep the site working.